The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children*
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role
1999 • 684 citations
Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS)
2002 • 343 citations
Rapid and Ultrarapid Opioid Detoxification Techniques
1998 • 183 citations
Binding of [3H]p-aminoclonidine to two sites, α2-adrenoceptors and imidazoline binding sites: distribution of imidazoline binding sites in rat brain
1990 • 102 citations
Dexmedetomidine to Facilitate Drug Withdrawal
2003 • 87 citations
The Use of Dexmedetomidine to Facilitate Opioid and Benzodiazepine Detoxification in an Infant
2004 • 80 citations
Prolonged Dexmedetomidine Infusion as an Adjunct in Treating Sedation-Induced Withdrawal
2003 • 77 citations
Myocardial catecholamine content after heart transplantation.
1990 • 74 citations
Movement disorder after withdrawal of fentanyl infusion
1991 • 70 citations
Hemodynamic Effects of Dexmedetomidine, an α2-Adrenergic Agonist, in Autonomically Denervated Dogs
1990 • 52 citations
Effect of dexmedetomidine, an α2-adrenergic agonist, in the isolated heart
1992 • 41 citations
Heart Rate Variability and Plasma Catecholamines in Patients During Opioid Detoxification
1999 • 35 citations
Imidazoline Receptors in the Heart: Characterization, Distribution, and Regulation
2002 • 33 citations
Dexmedetomidine Fails to Cause Hyperalgesia After Cessation of Chronic Administration
2003 • 28 citations
Dexmedetomidine Fails to Cause Hyperalgesia After Cessation of Chronic Administration
2003 • 15 citations
Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides
2004 • 14 citations
Arrhythmias and clinical electrophysiology of the transplanted human heart.
1990 • 9 citations